Ad campaign for the launch of Basaglar, a new basal insulin treatment.
Basaglar is a long-acting insulin that we positioned as the starter insulin, coining the term "beginsulin" for the launch
The Journal Ad and MVA above were part of our initial launch rollout. Prior to our web launch, these pieces were the first look at our brand and clinical results.
The fully responsive basaglar.com was a huge success, both in traffic and positive responses from patients and HCPs alike